Back to News
Market Impact: 0.15
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc.
Source: globenewswire.com
Legal & Litigation
Pomerantz LLP announced an investigation into claims on behalf of Ultragenyx Pharmaceutical investors. The notice provides contact information but does not specify the claims, alleged conduct, or any financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
RARE-0.60
More News
- Australia top court rules against coal mine expansion, citing climate harm
- CNN, CBS News now under one roof as Paramount-Warner Bros merger closes
- Sigma Lithium stock rises after court upholds mining licenses
- Skydance Shares Slide After Merger With Warner Bros. Discovery
- Corteva just underwent a big spinoff. JPMorgan says the agriculture stock is now poised for big gains
- Netlist stock: why Micron will pay NLST $30M a quarter for 5 years